Markets.com Logo

EMCURE

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1480.982$
  • Previous Close
    1505.4521$
  • 52 Week Change
    689.57$
  • Day Range
    -24.47$
  • 52 Week High/Low
    887.1655$ - 1576.7396$
  • Dividend Per Share
    0
  • Market cap
    282 954 M$
  • EPS
    11.06
  • Beta
    --
  • Volume
    --

About

EMCURE.NSE represents the stock of Emcure Pharmaceuticals Limited, a publicly traded Indian pharmaceutical company listed on the National Stock Exchange of India (NSE). Emcure focuses on developing, manufacturing, and marketing a wide range of pharmaceutical products, including generics, branded formulations, and biosimilars, across various therapeutic areas like gynecology, cardiology, and oncology. Investors can trade this stock on the NSE, with its price reflecting market sentiment and the company's financial performance.
Top 3 tech stocks to buy in 2026: Nebius (NBIS), MSTR stock, AAPL stock

Top 3 tech stocks to buy in 2026: Nebius (NBIS), MSTR stock, AAPL stock

Ghko B|--
BitGo crypto IPO: BitGo (BTGO) stock soars 20%, is BitGo a good buy?

BitGo crypto IPO: BitGo (BTGO) stock soars 20%, is BitGo a good buy?

Ghko B|--
S&P 500 forecast: Is the S&P 500 expected to go up in 2026?

S&P 500 forecast: Is the S&P 500 expected to go up in 2026?

Ghko B|--
Gold hits a new record above $4800: What is gold price prediction for 2026?

Gold hits a new record above $4800: What is gold price prediction for 2026?

Frances Wang|--
Trending tech stocks analysis: Intel stock jumps 12%, NVDA shares up 3%

Trending tech stocks analysis: Intel stock jumps 12%, NVDA shares up 3%

Frances Wang|--
Forex CFD trading platform reviews 2026: markets.com, IG, Avatrade

Forex CFD trading platform reviews 2026: markets.com, IG, Avatrade

Ghko B|--
ARK 21shares Bitcoin ETF (ARKB) analysis: Is ARKB a good investment?

ARK 21shares Bitcoin ETF (ARKB) analysis: Is ARKB a good investment?

Ghko B|--

Factors

Financial Performance: Revenue growth, profitability (net profit margin), and earnings per share (EPS) directly impact investor confidence.

Industry Trends: Overall growth and performance of the pharmaceutical sector and specific segments (like generics, APIs) influence investor sentiment.

Regulatory Environment: Changes in drug pricing regulations, patent laws, and approvals by regulatory bodies like DCGI affect future revenue potential.

Competition: Emergence of new players or aggressive pricing strategies by existing competitors can affect market share and profitability.

Macroeconomic Factors: Inflation, interest rates, and exchange rates impact operational costs and overall investor risk appetite.

Company-Specific News: Announcements about new drug launches, acquisitions, collaborations, or setbacks in clinical trials can cause significant price fluctuations.

Investor Sentiment: General market optimism or pessimism and news coverage about the company affect demand for its shares.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

S&P 500 trading for beginners: How to trade S&P 500 CFDs with markets.com?

S&P 500 trading for beginners: How to trade S&P 500 CFDs with markets.com?

Ghko B|--
Crypto day trading: How to day trade crypto CFDs with markets.com?

Crypto day trading: How to day trade crypto CFDs with markets.com?

Ghko B|--
Leverage trading: Difference between margin calls and forced liquidation

Leverage trading: Difference between margin calls and forced liquidation

Ghko B|--